The heterogeneous nuclear ribonucleoprotein U (HNRNPU) gene encodes a widely expressed nucleoplasmic protein that binds DNA and RNA, interacts with the nuclear matrix, organizes chromatin, regulates gene accessibility, and participates in transcription. Like other HNRNPs, it can enhance or repress splicing in a context-dependent manner. Heterozygous, often de novo mutations in HNRNPU are associated with a neurodevelopmental disorder (NDD) characterized by intellectual disability, developmental delay, epileptic seizures, and craniofacial dysmorphism. We hypothesize that phenotypes in this disorder stem from an excitation-inhibition imbalance in the developing brain. Using advanced organoid models, we aim to identify the underlying molecular processes in HNRNPU mutants that disrupt cortical development and alter the excitation-inhibition balance, paving the way for new therapies for HNRNPU-related NDD.